0001178913-22-002412.txt : 20220621 0001178913-22-002412.hdr.sgml : 20220621 20220621071516 ACCESSION NUMBER: 0001178913-22-002412 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220616 FILED AS OF DATE: 20220621 DATE AS OF CHANGE: 20220621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Quigley Jill M. CENTRAL INDEX KEY: 0001799780 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38807 FILM NUMBER: 221026022 MAIL ADDRESS: STREET 1: TWO COMMERCE SQUARE, 2001 MARKET STREET STREET 2: 28TH FLOOR CITY: PHILADELPHIA STATE: PA ZIP: 19103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Chemomab Therapeutics Ltd. CENTRAL INDEX KEY: 0001534248 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813676773 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: KIRYAT ATIDIM, BUILDING 7 CITY: TEL AVIV STATE: L3 ZIP: 6158002 BUSINESS PHONE: 972-77-331-0156 MAIL ADDRESS: STREET 1: KIRYAT ATIDIM, BUILDING 7 CITY: TEL AVIV STATE: L3 ZIP: 6158002 FORMER COMPANY: FORMER CONFORMED NAME: Anchiano Therapeutics Ltd. DATE OF NAME CHANGE: 20180906 FORMER COMPANY: FORMER CONFORMED NAME: BioCancell Ltd. DATE OF NAME CHANGE: 20111104 3 1 ownership.xml X0206 3 2022-06-16 0 0001534248 Chemomab Therapeutics Ltd. CMMB 0001799780 Quigley Jill M. C/O CHEMOMAB THERAPEUTICS LTD. 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CA 94404 1 0 0 0 Option to Purchase American Depositary Shares 3.25 2032-06-16 American Depositary Shares 13640 D Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. These options vest and become exercisable in equal monthly installments over a 36 month period commencing on June 16, 2022, subject to the Reporting Person's continued service. /s/ Jill M. Quigley 2022-06-21